In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research ...
Highlights,Several major investment firms have adjusted their stakes in Axsome Therapeutics, reflecting evolving market ...
Highlights,Financial institutions have adjusted their outlook on Axsome Therapeutics, revising expectations.,Institutional ...
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price target raised by equities research analysts at Wells Fargo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback